| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |